Enhertu 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQU8Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,262
Award facts
- Contract value 100% obligated
- $19,262.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,262.40 to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, an oncology medication, with a completion date of February 10, 2026. The contract employs firm fixed-price pricing and was awarded without a set-aside designation on January 20, 2026. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc.'s, significantly larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor that competes successfully in open competition for federal medical procurement needs. The company's extensive portfolio of federal contracts demonstrates its capability to deliver a wide range of medications across multiple therapeutic domains to support military treatment facilities and veteran healthcare programs. This particular delivery order for Enhertu reflects the company's role in supplying specialized oncology pharmaceuticals to support the Defense Health Agency and other federal healthcare systems, consistent with the DLA Medical Supply Chain's mission to ensure pharmaceutical availability for military personnel and related beneficiaries.
Quick answers
Who was awarded contract SPE2DR26FQU8Z?
SPE2DR26FQU8Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FQU8Z worth?
The government has obligated $19,262 on SPE2DR26FQU8Z.
Is contract SPE2DR26FQU8Z an order under another contract?
Yes. SPE2DR26FQU8Z is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQU8Z competed?
The extent of competition for SPE2DR26FQU8Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award